ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 139 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $11,949 | -22.0% | 3,610 | -22.9% | 0.00% | – |
Q1 2024 | $15,310 | -43.1% | 4,682 | -38.9% | 0.00% | – |
Q4 2023 | $26,908 | -92.2% | 7,666 | -85.2% | 0.00% | -100.0% |
Q3 2023 | $345,336 | -27.4% | 51,697 | -8.8% | 0.00% | 0.0% |
Q2 2023 | $475,814 | +411.6% | 56,712 | +170.6% | 0.00% | – |
Q1 2022 | $93,000 | -11.4% | 20,956 | -20.0% | 0.00% | – |
Q4 2021 | $105,000 | -54.3% | 26,203 | 0.0% | 0.00% | – |
Q3 2021 | $230,000 | -69.7% | 26,203 | -60.9% | 0.00% | -100.0% |
Q2 2021 | $759,000 | +772.4% | 66,960 | +90.6% | 0.00% | – |
Q1 2020 | $87,000 | -56.9% | 35,132 | +1.2% | 0.00% | – |
Q4 2019 | $202,000 | +10.4% | 34,724 | 0.0% | 0.00% | – |
Q3 2019 | $183,000 | -12.0% | 34,724 | 0.0% | 0.00% | – |
Q2 2019 | $208,000 | -30.4% | 34,724 | +5.0% | 0.00% | -100.0% |
Q1 2019 | $299,000 | +9.1% | 33,068 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $274,000 | -18.5% | 33,068 | +35.7% | 0.00% | 0.0% |
Q3 2018 | $336,000 | +73.2% | 24,369 | 0.0% | 0.00% | – |
Q2 2018 | $194,000 | – | 24,369 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,155,300 | $4,621,000 | 2.77% |
Knoll Capital Management, LLC | 759,405 | $3,038,000 | 1.67% |
ACUTA CAPITAL PARTNERS, LLC | 500,000 | $2,000,000 | 0.84% |
Perceptive Advisors | 19,807,758 | $79,232,000 | 0.61% |
Mesirow Financial Investment Management, Inc. | 48,711 | $195,000 | 0.56% |
Ghost Tree Capital, LLC | 300,000 | $1,200,000 | 0.43% |
Stonepine Capital Management, LLC | 200,000 | $800,000 | 0.37% |
APOGEM CAPITAL LLC | 86,730 | $347,000 | 0.23% |
JOHNSON & JOHNSON | 394,834 | $1,579,000 | 0.18% |
Affinity Asset Advisors, LLC | 100,759 | $403,000 | 0.15% |